Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Filters

API Status

CommercialPipeline

Alimentary tract & metabolism

Antifungal agentAnti-infectives for systemic useAntipyretic, analgesic and anti-inflammatoryAntineoplastic & immunomodulating agentsBlood & blood forming organsCardiovascular systemGenito-urinary system & sex hormonesInjectable FormsMusculo-skeletal systemNervous systemOpthalmological preparationsRespiratory systemOncology

Available EU DMF/CEP/US DMF

Injectable Forms

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

    D

  • Dapagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formAmorphous

    CAS No.461432-26-8

    View more

  • Dapagliflozin propanediol monohydrate

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline SC-3

    CAS No.960404-48-2

    View more

  • Disulfiram

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic form

    CAS No.97-77-8

    View more
    • E

  • Empagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline anhydrous

    CAS No.864070-44-0

    View more
    • L

  • Linagliptin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMix of form A & B

    CAS No.668270-12-0

    View more
    • S

  • Sitagliptin hydrochloride

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formPolymorphic form III

    CAS No.862156-92-1

    View more

  • Sodium salicylate

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMonoclinic form (space group P21/m)

    CAS No.54-21-7

    View more